Abstract Some novel triazolo [1,5-a]pyridine (4-6), thiazolo[3,2-a]pyridine (7), thiazolo[3,2-a]pyrimidines (9, 11), oxoimidazo[1,2-a]pyrimidine (10), and pyrimido[2,1-b]quinazoline (12) have been synthesized. The structures of target compounds were confirmed by elemental analyses and spectral data. The antimicrobial activity of some of the target synthesized compounds were tested against various microorganisms such as Salmonella typhimurium, Pseudomonas aeruginos and Staphylococcus aureus (bacteria), Aspergillus flavus (fungus), and Candida albicans (yeast fungus) by the disc diffusion method. In general, the novel synthesized compounds showed a good antimicrobial activity against these microorganisms.
Introduction
The treatment of bacterial infections still remains an important and challenging therapeutic problem because of factors that include emerging infectious diseases and the increasing number of multi-drug-resistant microbial pathogens. In spite of the large number of antibiotics and chemotherapeutics available for medical use, the emergence of old and new antibiotic-resistant bacterial strains in recent decades constitutes a substantial need for new classes of antibacterial agents [1] . Condensed heterocyclic systems containing triazolo[1, 5-a] pyridine are characterized by significant pharmacological activity. These types of compounds exhibit antitumor, antioxidant, analgesic, anti-inflammatory, antibacterial, antifungal activity, etc. [2] [3] [4] [5] [6] [7] . In addition to the previously mentioned properties, thiazolo [3,2-a] pyridines, also containing two fused heterocyclic moieties in one molecule, are found in a broad range of biologically active compounds and have many important bioactivities such as inhibitors of beta-amyloid production [8] , CDK2-cyclin-A [9] , and a-glucosidase [10] , potential uterus stimulants [11, 12] , and antibacterial and antifungal activities [13] , and are found to exhibit a broad spectrum of potent anticancer activity and are useful for chemotherapy of various cancers, such as leukemia, lung cancer, and melanoma [14] . On the other hand, certain pyrimidine derivatives are also known to exhibit diverse pharmacological properties such as effective bactericides and fungicides [15] , as antimalarial [16] , antioxidant [17, 18] , and antihypertensive agents, as adrenergic and neuropeptide antagonists [19] and having anti-HIV activities [20, 21] . Along with the varied biological activities of pyrimidine, other heterocycles fused with pyrimidines play an essential role in several biological processes and have a considerable chemical and pharmacological importance [22, 23] . In the view of these facts and as part of our efforts to discover potentially active new agents, we have synthesized some new triazolo[1,5-a]pyridine, thiazolo[3,2-a]pyridine, and dihydropyrimidinecarbonitrile, and their fused derivatives. The novel derivatives were characterized by spectral data and elemental analysis and tested for their antimicrobial activities.
Experimental
All melting points were uncorrected and were taken on a Boetius melting point microscope. The infrared (IR) spectra were recorded on a Bruker-Vector 22, Germany, using KBr discs at the microanalytical center, Cairo University.
1 HNMR spectra were performed on a Varian Gemini 300 MHz spectrometer and JEOL EX-270 MHz at the Central Services Laboratory, National Research Centre, Cairo, Egypt, using tetramethylsilane (TMS) as internal standard. All chemical shifts are quoted in d values using parts per million scale (ppm) downfield from TMS. Mass Spectra were recorded on a Hewlett-Packard 5988 A (1,000 Hz) instrument and Shimadzu GCMS-QP-1000EX mass spectrometer at 70 eV at Cairo University. Elemental analysis were performed by the Microanalytical unit at Cairo University and the results were within ±0.4 of the theoretical values. All reactions were monitored by TLC using precoated aluminum sheet silica gel Merck 60F 254 plates, and detection of the components was made by short and long UV light.
A mixture of freshly prepared cyanohydrazide (0.02 mol) and 2-((5-methylfuran-2-yl)methylene)malononitrile (1) (0.01 mol) in absolute ethanol (25 mL) containing a catalytic amount of piperidine was allowed to stir for 5 h at room temperature. The resulting precipitate was filtered off and washed several times with ethanol and crystallized from methanol to give 3 in 90 % yield; m.p. 00 -H), 3.52 (m, 2H, 5
A mixture of equimolar amounts of 3 and ethylacetoacetate was refluxed for 3 h in ethanol (25 mL 
A solution of (3) (0.002 mol) in freshly distilled acetic anhydride and acetic acid (1:1) was reflux for 10 h. The precipitate formed on cooling to room temperature was filtered off and crystallized from DMF to give compound (6) 
A solution of 1 (0.02 mol) and thioglycolic acid (0.01 mol) in ethanol (50 mL) and a catalytic amount of piperidine was refluxed for 5 h. The solvent was concentrated and the solid product was collected by filtration and recrystallized from ethanol to give the title compound (7) 1,2,3,4-Tetrahydro-6-(5-methylfuran-2-yl)-4-oxo-2-thioxopyrimidine-5-carbonitrile (8) A mixture of ethyl cyanoacetate (0.1 mol), thiourea (0.1 mol) and 5-methylfurfural (0.1 mol) in 50 mL sodium ethoxide (2.3 g, 0.1 mol) was stirred for 24 h at room temperature and poured onto ice-water, and acidified with diluted HCl to give precipitates, which were filtered off, dried, and crystallized from methanol to give compound 8 in 76 % yield; m.p. 
A mixture of carbonitrile 8 (0.01 mol) and phenacyl bromide (0.01 mol) was refluxed in ethanol for 5 h. After completion of the reaction, the precipitate formed on hot was filtered, washed with ethanol, and dried to give compound 9 in yield of 69 %; m.p. 
6,11-Dihydro-2-(5-methylfuran-2-yl)-4,6-dioxo-4H-pyrimido[2,1-b]quinazoline-3-carbonitrile (12)
A mixture of the thiouracil derivative 8 (0.01 mol) and anthranilic acid (0.01 mol) were refluxed in sodium ethoxide solution (0.3 g sodium metal in 100 mL absolute ethanol) for 12 h, cooled, and poured onto acidified ice-water. The obtained solid was filtered off, washed with water, dried, and crystallized from DMF/water to give compound 12, in yield of 57 %; mp. 
Results and discussion
1,6-Diamino-3,5-dicyano-4-(5-methylfuran-2-yl)-2-pyridone (3), [15] was prepared in a good yield by reacting 2-((5-methylfuran-2-yl)methylene)malononitrile (1) with cyanoacetohydrazide (2) On the other hand, the thioxopyrimidine heterocyclic core were constructed according to Biginelli reaction by a cyclo-condensation of equivalent molar quantities of 5-methylfurfural, thiourea, and ethyl cyanoacetate in sodium ethoxide solution. After neutralization with acid, the desired 5-cyano-4-oxo-6-(5-methylfuran-2-yl)-2-thioxo-1,2,3,4-tetrahydro-pyrimidine derivative (8) Antimicrobial assay
Preparation of microbial suspensions
Seven compounds were tested for their antimicrobial activities against highly pathogenic strains; one Gram-positive bacteria (Staphylococcus aureus), one Gramnegative bacteria (Escherichia coli O157) isolated from minced meat, and two mycotic strain (Candida albicans, Aspergillus flavus) isolated from mastitic milk. Agar disk diffusion (qualitative method) and minimum inhibitory concentration (MIC) (quantitative method) were used in this study. A suspension of bacterial and mycotic isolates were freshly prepared by inoculating fresh stock culture from each strain into separate broth tubes, each containing 7 mL of Muller Hinton Broth for bacterial strains and Sabaroud Dextrose broth for mycotic strain. The inoculated tubes were incubated at 37 and 28°C for 24 h, respectively. Serial dilutions were carried out for each strain; the dilution matching with 0.5 McFarland (about 1 9 10 8 cells/mL) was selected for screening of antimicrobial activities. Ciprofloxacin 100 lg/mL and fluconazole 100 lg/ mL were used as reference drugs (Oxoid). DMSO was used as control negative.
Determination of antimicrobial activity by disc-diffusion method [24] Muller Hinton and Sabaroud dextrose agar plates were prepared. Bacterial and fungal strains matching with 0.5 McFarland were spread onto the surface of the agar Scheme 2 Synthetic route for compounds [8] [9] [10] [11] [12] plates using sterile cotton swabs. For evaluation of antibacterial activities, Whatman no. 1 filter paper disks were saturated with 50 lL of the compound dissolved in DMSO (100 lg of the tested compound dissolved in 1 mL DMSO), others were saturated with 50 lL ciprofloxacin (100 lg/mL), and others 50 lL DMSO as control negative. The same method was used for evaluation of antimycotic activities using fluconazole (100 lg/mL). Disks were dried and then placed onto inoculated agar plates and left for 1 h at 25°C to allow a period of pre-incubation diffusion in order to minimize the effects of variation in time between the applications of different solutions. The plates were re-incubated at 37 and 28°C for 24 h for bacterial and mycotic isolates, respectively. After incubation, plates were observed for antimicrobial activities by determining the diameters of the zones of inhibition for each of the samples. For an accurate analysis, tests were run in triplicate for each strain to avoid any error.
Determination of minimum inhibitory concentration (MIC) [25]
Microtiter dilution plate quantitative method, i.e. the MIC was used for evaluation of the antimicrobial activity of tested compounds. Determination of MIC of extract against tested strains was achieved using 96-well sterile micro-plates. The first well contain the concentrated form of the tested compound used in the agar disk diffusion method (100 lg of the tested compound dissolved in 1 mL DMSO), then two-fold serial dilutions was carried out for the tested compounds, reference drugs (ciprofloxacin and fluconazole), and DMSO, Then, the wells were inoculated with 100 lL of tested isolates (0.5 McFarland, about 1 9 10 8 cells/mL) and incubated at 37-28°C for 24 h for bacterial and fungal strains, respectively. After incubation, plates were examined visually for bacterial or fungal growth precipitation. The experiment was repeated three times. The lowest concentration that showed complete hindrance of growth was taken as MIC. 
Biological evaluation
All the newly synthesized compounds were screened for their in vitro antibacterial activity against Gram-positive bacteria (S. aureus), and Gram-negative bacteria (E. coli) using ciprofloxacin as the standard drug (100 lg/mL). They were also evaluated for their in vitro antifungal activity against the mycotic isolates (C. albicans, A. flavus) using fluconazole as a standard antifungal drug (100 lg/mL).
The agar well diffusion method [20] was used in this investigation for determination of the preliminary antibacterial and antifungal activity and the results were recorded for each tested compound as the average diameter (in mm) of inhibition zones (IZ) of bacterial or fungal growth around the discs (Table 1 ). The minimum inhibitory concentrations (MIC) were recorded for compounds that showed promising growth inhibition using the two-fold serial dilution method [21] . The MIC (lg/mL) values against the tested bacterial and fungal isolates were recorded in (Table 2 ). The agar well diffusion method showed very weak activity of the compounds (3), (4a) and (6) against bacterial isolates comparing with reference drugs, while other compounds showing no hindrance of the tested compounds for the bacterial strains, The antimycotic activity were more promising for the compounds (3) and (4e) with mean zones of inhabitation equal to 16, 17, and 19 mm and 16 mm against C. albicans and A. flavus, respectively, followed by compound (6) which showed a zone of inhibition equaling 17 and 12 mm, then compounds (4a) and (4b) which showed zones of hindrance against C. albicans equalling 18 and 13 mm compared with reference drug (fluconozole) which give activity of 25 and 24 mm against C. albicans and A. flavus, respectively. MIC was carried out against mycotic strains only, and results against C. albicans showed that compound (4e) has the highest hindrance capability at dilution 0.19 followed by compounds (3) and (6) with MIC equal 1.56 against A. flavus. Compound (3) was the best with MIC 1.56 followed by compound (4e) with MIC equal to 3.125 compared with fluconazole which gave MIC equal to 0.097 for both tested strains. Fluconazole 100 mg/mL 0.097 0.097
